Genprex, Inc.
GNPX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001595248
No open-market purchases or sales by Genprex, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $154.9K in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Genprex, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 42
- −7 vs. Q1 2022
- Shares held
- 4.40M
- −368.8K (−7.7%) vs. Q1 2022
- Total value
- $6.11M
- −$4.66M (−43.3%) vs. Q1 2022
- New holders
- 2
- 10 more added
- Sold out
- 9
- 12 more reduced
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GNPX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $154.9K |
| Q1 2026 | 27 | $169.0K |
| Q4 2025 | 22 | $13.0K |
| Q3 2025 | 21 | $229.5K |
| Q2 2025 | 28 | $152.9K |
| Q1 2025 | 24 | $93.5K |
| Q4 2024 | 22 | $247.0K |
| Q3 2024 | 21 | $79.7K |
| Q2 2024 | 15 | $510.3K |
| Q1 2024 | 17 | $426.0K |
| Q4 2023 | 36 | $1.16M |
| Q3 2023 | 39 | $2.61M |
| Q2 2023 | 38 | $3.64M |
| Q1 2023 | 39 | $5.42M |
| Q4 2022 | 45 | $5.84M |
| Q3 2022 | 43 | $6.29M |
| Q2 2022 | 42 | $6.11M |
| Q1 2022 | 50 | $10.8M |
| Q4 2021 | 47 | $9.78M |
| Q3 2021 | 49 | $15.8M |
| Q2 2021 | 59 | $19.5M |
| Q1 2021 | 72 | $35.4M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Genprex, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 1 | $0 | 0.00% | −1,090−99.9% | Reduced |
| TCI Wealth Advisors, Inc. | 300 | $0 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 177 | $0 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 73 | $101 | 0.00% | 00.0% | Unchanged |
| American Portfolios Advisors | 200 | $278 | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 850 | $1.00K | 0.00% | 00.0% | Unchanged |
| High Net Worth Advisory Group LLC | 1,000 | $1.00K | 0.00% | 00.0% | Unchanged |
| Burleson & Company, LLC | 400 | $1.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,788 | $2.00K | 0.00% | −6,329−78.0% | Reduced |
| Wells Fargo & Company | 1,482 | $2.00K | 0.00% | +23+1.6% | Added |
| Royal Bank of Canada | 3,021 | $4.00K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 5,618 | $8.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 9,062 | $13.0K | 0.00% | +650+7.7% | Added |
| Meeder Asset Management Inc | 10,641 | $14.0K | 0.00% | −35−0.3% | Reduced |
| Pekin Hardy Strauss, Inc. | 12,578 | $17.0K | 0.00% | +12,578 | New |
| David Loasby | 15,000 | $21.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 17,569 | $24.0K | 0.00% | −1,190−6.3% | Reduced |
| TCG Advisory Services, LLC | 17,000 | $24.0K | 0.01% | +1,000+6.3% | Added |
| Morgan Stanley | 17,421 | $25.0K | 0.00% | −16,101−48.0% | Reduced |
| Goldman Sachs Group Inc | 21,394 | $30.0K | 0.00% | −100,179−82.4% | Reduced |
| Dimensional Fund Advisors LP | 22,644 | $31.0K | 0.00% | +1,960+9.5% | Added |
| Virtu Financial LLC | 29,710 | $41.0K | 0.00% | +9,069+43.9% | Added |
| Charles Schwab Investment Management Inc | 29,742 | $42.0K | 0.00% | 00.0% | Unchanged |
| HighTower Advisors, LLC | 32,079 | $44.0K | 0.00% | +20,900+187.0% | Added |
| StoneX Group Inc. | 35,150 | $48.9K | 0.01% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 40,181 | $56.0K | 0.00% | +40,181 | New |
| Spire Wealth Management | 45,000 | $63.0K | 0.00% | 00.0% | Unchanged |
| Staley Capital Advisers Inc | 50,000 | $69.0K | 0.00% | 00.0% | Unchanged |
| IHT Wealth Management, LLC | 52,375 | $73.0K | 0.01% | 00.0% | Unchanged |
| Silvercrest Asset Management Group LLC | 56,000 | $78.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 75,401 | $105.0K | 0.00% | −3,290−4.2% | Reduced |
| Price T Rowe Associates Inc | 80,400 | $112.0K | 0.00% | +3,300+4.3% | Added |
| Verus Capital Partners, LLC | 89,500 | $124.0K | 0.02% | +4,000+4.7% | Added |
| Cypress Capital, LLC | 100,000 | $139.0K | 0.02% | 00.0% | Unchanged |
| Millennium Management LLC | 128,962 | $179.0K | 0.00% | −85,546−39.9% | Reduced |
| State Street Corp | 129,739 | $180.0K | 0.00% | −460−0.4% | Reduced |
| Group One Trading, L.P. | 157,522 | $219.0K | 0.01% | −57,130−26.6% | Reduced |
| UBS Group AG | 271,766 | $378.0K | 0.00% | −385−0.1% | Reduced |
| Geode Capital Management, LLC | 431,976 | $600.0K | 0.00% | +17,583+4.2% | Added |
| BlackRock Inc. | 577,788 | $803.0K | 0.00% | −4,096−0.7% | Reduced |
| Vanguard Group Inc | 1,824,935 | $2.54M | 0.00% | +12,738+0.7% | Added |
| IFP Advisors, Inc | 4,000 | – | – | 00.0% | Unchanged |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −123,618−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −35,958−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −19,950−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −12,200−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −11,000−100.0% | Sold out |
| Eqis Capital Management, Inc. | 0 | $0 | 0.00% | −10,287−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −2,168−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −1,800−100.0% | Sold out |
| Glassman Wealth Services | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | – | – | – | – | Not filed |